Table 2. Glucose, insulin and lipids throughout pregnancy in the total cohort and in groups according to BMI.
Total cohort n = 1031 | BMI<25 n = 628 | BMI 25–29.9 = 286 | BMI>30 = 89 | Difference between groups | |||||
---|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||
Fasting glucose v1 | 4.61 | 0.4 | 4.54 | 0.4 | 4.68 | 0.4 | 4.84 | 0.4 | # |
Fasting glucose v4 | 4.54 | 0.5 | 4.45 | 0.5 | 4.64 | 0.5 | 4.90 | 0.5 | # |
Δ Fasting glucose v4-v1 | -0.06* | 0.5 | -0.09* | 0.5 | -0.04 | 0.4 | 0.07 | 0.5 | # |
Insulin v1 (median/IQR) | 27 | 18–40 | 23 | 15–33 | 33 | 23–46 | 49.5 | 33–75 | «» |
Insulin v4 (median/IQR) | 42 | 28–65 | 35 | 24–50 | 55 | 37–80 | 76 | 58–124 | «» |
Δ Insulin v4-v1 | 15¤ | 14¤ | 25¤ | 26.5¤ | «» | ||||
Total chol v1 | 4.92 | 0.9 | 4.85 | 0.9 | 4.99 | 0.8 | 5.14 | 1.0 | # |
Tot chol v4 | 6.71 | 1.3 | 6.80 | 1.3 | 6.64 | 1.2 | 6.42 | 1.5 | # |
Δ Tot chol v4-v1 | 1.8* | 1.0 | 1.95* | 1.0 | 1.66* | 1.0 | 1.28* | 1.0 | # |
HDL chol v1 | 1.8 | 0.4 | 1.86 | 0.4 | 1.75 | 0.4 | 1.55 | 0.4 | # |
HDL chol v4 | 1.72 | 0.4 | 1.79 | 0.5 | 1.67 | 0.4 | 1.53 | 0.4 | # |
Δ HDL chol v4-vl | -0.07* | 0.4 | -0.07* | 0.3 | -0.08* | 0.4 | -0.006 | 0.3 | ns |
LDL chol v1 | 2.58 | 0.8 | 2.49 | 0.8 | 2.66 | 0.7 | 2.88 | 0.8 | # |
LDL chol v4 | 3.87 | 1.2 | 3.94 | 1.2 | 3.78 | 1.0 | 3.62 | 1.3 | # |
Δ LDL chol V4-v1 | 1.29* | 0.9 | 1.44* | 0.9 | 1.13* | 0.9 | 0.73* | 0.8 | # |
Triglycerides v1 | 1.19 | 0.7 | 1.10 | 0.4 | 1.28 | 0.5 | 1.57 | 0.5 | # |
Triglycerides v4 | 2.48 | 0.8 | 2.39 | 0.8 | 2.61 | 0.9 | 2.79 | 0.9 | # |
Δ Triglycer v4-v1 | 1.3* | 0.7 | 1.29* | 0.6 | 1.35* | 0.7 | 1.23* | 0.8 | ns |
# p<0.05 One-way ANOVA, comparing differences between groups
«»p<0.001 Kruskal Wallis test, comparing differences between groups, non-parametric test
* p<0.05 paired t-test, comparing longitudinal changes in each individual
¤ p<0.01Wilcoxon Signed Rank Test, comparing longitudinal changes in each individual, non-parametric test